Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
63.38
-2.88 (-4.35%)
At close: May 09, 2025, 3:59 PM
64.25
1.37%
After-hours: May 09, 2025, 04:51 PM EDT
-4.35% (1D)
| Bid | 62.85 |
| Market Cap | 5.4B |
| Revenue (ttm) | 118.53M |
| Net Income (ttm) | -164.02M |
| EPS (ttm) | -2 |
| PE Ratio (ttm) | -31.69 |
| Forward PE | 168.71 |
| Analyst | Strong Buy |
| Ask | 65 |
| Volume | 1,819,299 |
| Avg. Volume (20D) | 1,439,406 |
| Open | 66.51 |
| Previous Close | 66.26 |
| Day's Range | 62.85 - 67.86 |
| 52-Week Range | 11.39 - 74.18 |
| Beta | 0.20 |
About VRNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Verona Pharma has released their quartely earnings
on Apr 29, 2025:
1 week ago
+6.38%
Verona Pharma shares are trading higher after the ...
Unlock content with
Pro Subscription
2 months ago
+5.67%
Verona Pharma shares are trading higher after the company reported better-than-expected Q4 financial results.
1 month ago · seekingalpha.com
Verona Pharma's Bull Case Holds, But Lifecycle Extension Is CriticalOhtuvayre's robust launch for COPD treatment exceeded expectations, with Q4 revenue of $36.6 million and FY24 revenue of $42.3 million, indicating strong market demand. Verona's financial health is so...
